0001493152-22-016081.txt : 20220607 0001493152-22-016081.hdr.sgml : 20220607 20220607161017 ACCESSION NUMBER: 0001493152-22-016081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220601 FILED AS OF DATE: 20220607 DATE AS OF CHANGE: 20220607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cundy Kenneth C CENTRAL INDEX KEY: 0001322959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40388 FILM NUMBER: 221001324 MAIL ADDRESS: STREET 1: 1455 ADAMS DRIVE, SUITE 2050 STREET 2: MENLO BUSINESS PARK CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201 CITY: LAKEWAY STATE: TX ZIP: 78734 4 1 ownership.xml X0306 4 2022-06-01 0 0001815974 Anebulo Pharmaceuticals, Inc. ANEB 0001322959 Cundy Kenneth C C/O ANEBULO PHARMACEUTICALS, INC. 1415 RANCH ROAD 620 SOUTH, SUITE 201 LAKEWAY TX 78734 0 1 0 0 Chief Scientific Officer Option to purchase Common Stock 2.91 2022-06-01 4 A 0 350169 0 A 2022-07-01 2027-06-30 Common Stock 350169 350169 D Mr. Cundy received a stock option to purchase shares of the Issuer's common stock pursuant to the Issuer's 2020 Stock Incentive Plan: (a) 233,446 shares will vest in equal quarterly installments from July 1, 2022 through April 1, 2026. (b) 116,723 shares will vest upon completion of certain milestone events. /s/ Kenneth C Cundy 2022-06-07